The group’s principle activities include developing, manufacturing and commercializing immunobiotics. The group’s products include Biothrax. The group operates through two segments namely, biodefense and commercial. The group operates from the United States.
Executive Information
Name
Title
Email
Fuad El-Hibri
Chmn., CEO, Pres.
N/A
Michael Langford
Pres. - Emergent Product Development Gaithersburg Inc